Member Exclusive

Novel oral iron drug may be effective for anemic kidney disease patients

Researchers at Stanford University (Stanford, CA, USA) may have identified an alternative treatment for anemia in patients with chronic kidney disease with a new oral iron formulation.

Go to the profile of Peter Brown
Jan 17, 2017

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.